YOLFTbeta
iZafe Group AB Series B

iZafe Group AB Series B

IZAFE-B · ST · Healthcare / Medical Instruments & Supplies

0.224SEK+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.224
Open0.21
Day Range0.20 – 0.23
52-Week Range0.251 – 0.80
Volume163.02K
Market Cap143.82M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.05
Dividend Yield0.00%
Beta-0.06
50-Day Avg0.3155
200-Day Avg0.3826

About

iZafe Group AB (publ), a medical technology company, develops and markets medical and digital security solutions in Sweden and internationally. It offers Dosell, an automated medication dispenser for medication at home; and Pilloxa, an app for clinical studies, as well as to engage and involve patients. The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019. iZafe Group AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Anders Segerstrom
  • Employees14
  • HeadquartersDavid Bagares Gata 3, Stockholm, Sweden, 111 38, Sweden
  • Websitehttps://www.izafe.se

Leadership

  • Mr. Anders SegerstromChief Executive Officer · b. 1985
  • Ms. Barbro Stahle SjonellCo-Founder
  • Mr. Marius SandbergChief Financial Officer · b. 1997
  • Mr. Mikael SvenssonChief Operating Officer · b. 1966
  • Mr. Erik GillsbroChief Technology Officer · b. 1991
  • Ms. Helena RonnqvistCMO & BUM of Pilloxa · b. 1984

Financials

Income Statement

Currency: SEK2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.75K26.42K39.10K5.70K--0155.00K7.57M14.33M8.90M442.00K729.00K1.82M7.95M5.99M
Growth (%)-+604.51%+48.00%-85.43%----+4784.52%+89.25%-37.86%-95.04%+64.93%+149.93%+336.55%-24.68%
Cost of Revenue--1.37M1.23M-2.39M1.46M4.89M18.30M36.35M1.26M1.58M606.00K1.53M9.59M21.55M
Gross Profit3.75K26.42K-1.34M-1.22M--2.39M-1.46M-4.74M-10.73M-22.03M7.64M-1.14M123.00K293.00K-1.63M-15.56M
Gross Margin100.00%100.00%-3414.36%-21405.93%----3056.77%-141.75%-153.73%85.86%-257.47%16.87%16.08%-20.54%-259.71%
Operating Expense5.90M4.95M1.65M7.35M-535.64K5.01M-500.00K7.00K539.00K19.76M32.13M23.53M35.93M17.79M2.83M
Operating Income-5.90M-4.92M-2.99M-8.57M-3.51M-2.93M-6.47M-4.24M-10.74M-22.57M-12.11M-33.27M-23.40M-35.63M-19.43M-18.39M
Operating Margin-157298.05%-18620.98%-7638.94%-150337.75%----2734.19%-141.84%-157.49%-136.03%-7527.83%-3210.43%-1955.82%-244.22%-306.96%
EBITDA-4.26M-3.28M-1.78M-1.67M-1.12M-535.64K-5.06M-3.82M-10.17M-20.76M-10.67M-32.35M-21.94M-15.62M-15.49M-13.63M
EBITDA Margin-113710.32%-12433.70%-4554.18%-29315.78%----2464.52%-134.32%-144.86%-119.83%-7319.00%-3009.47%-857.14%-194.81%-227.42%
Net Income-5.91M-4.94M-2.92M-7.23M-3.17M-2.60M-6.36M-4.27M-11.31M-23.12M-12.75M-36.27M-23.53M-32.17M-20.51M-16.68M
Net Income Margin-157526.53%-18704.64%-7462.56%-126867.08%----2754.19%-149.41%-161.33%-143.24%-8207.01%-3227.16%-1765.92%-257.85%-278.35%
R&D---------3.92M3.92M3.92M2.90M3.13M2.83M-
R&D as % of Total Revenue---------27.38%44.07%887.78%397.81%171.62%35.63%-
Interest Expense8.57K22.18K40.69K90.81K98.09K107.21K106.97K31.00K391.00K614.00K731.00K3.00M182.00K240.00K1.12M7.00K
Interest Expense % of Total Revenue228.48%83.96%104.06%1593.70%---20.00%5.16%4.29%8.21%679.19%24.97%13.17%14.12%0.12%

Balance Sheet

Currency: SEK2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets4.86M3.56M24.10M17.11M15.10M12.42M8.09M13.71M43.58M71.75M35.08M48.43M50.70M34.61M24.23M35.63M
Total Liabilities798.87K474.05K5.18M5.42M6.06M3.70M2.68M2.53M33.46M34.86M5.62M7.70M11.74M9.26M14.50M23.95M
Total Equity4.06M3.08M18.92M11.69M9.04M8.72M5.42M11.19M10.12M36.89M29.46M40.73M38.96M25.35M9.73M11.69M
Cash50.00K50.00K131.30K82.86K270.44K109.75K3.56M3.58M1.21M7.47M2.55M18.73M1.70M5.83M2.15M1.67M
Total Debt676.73K267.35K466.15K1.39M1.92M1.27M975.00K675.00K11.48M10.94M750.00K4.98M4.00M2.52M6.58M63.00K
Net Debt626.73K217.35K334.85K1.30M1.65M1.17M-2.59M-2.91M10.27M3.47M-1.80M-17.64M2.30M-3.31M4.43M-1.67M

Cash Flow

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.62M-941.32K-829.55K-1.77M-4.32M-3.72M-1.41M-15.32M-24.57M-33.49M-21.46M-11.26M-11.36M-14.56M
Investing Cash Flow-1.71M-28.68K-44.07K-17.63K-1.13M-6.00M-27.58M-5.57M19.04M-214.00K-2.51M-1.46M-1.02M2.15M
Financing Cash Flow3.42M921.55K1.06M1.63M8.90M9.74M26.61M27.15M604.00K49.88M6.94M16.85M8.69M11.93M
Capital Expenditure1.71M28.68K44.07K17.63K1.13M5.97M21.56M4.17M1.58M214.00K2.66M1.46M1.02M14.56M
Free Cash Flow-3.34M-969.99K-873.62K-1.79M-5.44M-9.69M-22.97M-19.49M-26.14M-33.71M-24.12M-12.71M-12.72M-15.22M
FCF to OCF205.69%103.05%105.31%100.99%126.13%260.55%1629.01%127.22%106.42%100.64%112.39%112.94%112.03%104.53%

Earnings

Report DateMar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014May 4, 2017Aug 29, 2017Dec 14, 2017Mar 22, 2018May 24, 2018Aug 29, 2018Oct 24, 2018Feb 28, 2019May 6, 2019Aug 28, 2019Oct 25, 2019Feb 20, 2020May 11, 2020Aug 17, 2020Nov 9, 2020Feb 19, 2021Apr 29, 2021Aug 4, 2021Nov 29, 2021Feb 18, 2022Apr 29, 2022Aug 26, 2022Nov 7, 2022Feb 3, 2023May 12, 2023Aug 25, 2023Nov 17, 2023Feb 9, 2024Apr 26, 2024Aug 30, 2024Nov 1, 2024Feb 14, 2025Apr 25, 2025Aug 29, 2025Nov 4, 2025Feb 16, 2026Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------0.12-0.13-0.10-0.06--0.23-0.19-0.15-0.15-----------0.00------
EPS Actual-0.12-0.08-0.06-0.13-0.09-0.17-0.05-0.15-0.10-0.09-0.09-0.11-0.05-0.07-0.12-0.14-0.21-0.30-0.15-0.16-0.31-0.35-0.19-0.30-0.20-0.20-0.21-0.28-0.30-0.22-0.17-0.18-0.10-0.10-0.10-0.05-0.03-0.02-0.02-0.07-0.02-0.02-0.02-0.02-0.01-0.01-0.01-0.01-0.02-0.02
Surprise------------------------150.00%-53.85%-100.00%-250.00%--30.43%-14.58%-17.75%-21.73%------------------
Timing---------------Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market---Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-Pre-market-----

Key Statistics & Ratios

Market Cap143.82M
Enterprise Value118.02M
Trailing P/E0.00
Forward P/E0.00
Price / Sales16.73
Price / Book7.47
EPS-0.05
Book Value0.04
Revenue (TTM)8.60M
Gross Profit (TTM)4.74M
EBITDA-20.17M
Profit Margin-259.86%
Operating Margin-284.62%
Return on Equity-162.61%
Return on Assets-42.95%
Shares Outstanding429.99M
Shares Float422.53M
Beta-0.06
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Sep 29, 2021176:163
  • Apr 18, 2012994:597